ATI 2341
Purity: ≥95%
Biological Activity
ATI 2341 is a CXCR4 allosteric agonist (EC50 = 194 nM). Induces chemotaxis in CXCR4-expressing cells in vitro. Mobilizes polymorphonuclear neutrophils (PMNs) and hematopoietic stem and progenitor cells (HSPCs) from bone marrow niche in vivo. Exhibits biased signaling towards Gi proteins over G13 and β-arrestin.Technical Data
(Modification: Met-1 = N-terminal Palmitoyl)
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells.
Tchernychev et al.
Proc.Natl.Acad.Sci.U.S.A., 2010;107:22255 -
Studying the binding interactions of allosteric agonists and antagonists of the CXCR4 receptor.
Planesas et al.
J.Mol.Graph Model., 2015;60:1 -
Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein.
Quoyer et al.
Proc.Natl.Acad.Sci.U.S.A., 2013;110:E5088
Product Datasheets
Reconstitution Calculator
Molarity Calculator
FAQs
No product specific FAQs exist for this product, however you may
View all Peptide FAQsReviews for ATI 2341
There are currently no reviews for this product. Be the first to review ATI 2341 and earn rewards!
Have you used ATI 2341?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image